Kantonsspital Graubuenden - Hauptstandort

Chur 7000

0 studies enrolling now · 1 studies all time

What they study most

EGFR Exon 19 Deletion, EGFR L858R, Nonsquamous Non-small Cell Lung Cancer

Studies at this site

• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling